Role of Sensory Nerve Peptides Rather than Mast Cell Histamine in Paclitaxel Hypersensitivity

American Journal of Respiratory and Critical Care Medicine

Volumn 169, Issue 1, 2004, Pages 113-119

  Itoh, Yoshinori ^b   Sendo, Toshiaki ^a   Hirakawa, Toshio ^b   Goromaru, Takeshi ^b   Takasaki, Shinya ^b   Yahata, Hideaki ^b   Nakano, Hitoo ^b   Oishi, Ryozo ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b NONE

Author keywords

Hypersensitivity; Paclitaxel; Sensory nerve

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE[8-37]; CAPSAICIN; DEXAMETHASONE; DIPHENHYDRAMINE; FAMOTIDINE; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; LANEPITANT; NAFAMSTAT MESILATE; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 2 RECEPTOR ANTAGONIST; NEUROKININ A; NEUROPEPTIDE; PACLITAXEL; SAREDUTANT; SUBSTANCE P; TRYPTASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DRUG POTENTIATION; LUNG ALVEOLUS OXYGEN TENSION; LUNG EDEMA; MALE; MAST CELL; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; WILD TYPE;

EID: 1242320973     PISSN: 00030805     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200307-901oc     Document Type: Article

References (40)

1. Kris MG, O'Connell JP, Gralla RJ, Wertheim MS, Parente RM, Schiff PB, Young CW. Phase I trial of taxol given as a 3-hour infusion every 21 days. Cancer Treat Rep 1986;70:605-607.
2. Weiss RB, Donehower RC, Wiernik PH, Ohnuma T, Gralla RJ, Trump DL, Baker JR Jr, Van Echo DA, Von Hoff DD, Leyland-Jones B. Hypersensitivity reactions from taxol. J Clin Oncol 1990;8:1263-1268.
3. Cormio G, Di Vagno G, Melilli GA, Cazzolla A, Di Gesu G, Carriero C, Cramarossa D, Loverro G, Selvaggi L. Hypersensitivity reactions in ovarian cancer patients receiving paclitaxel. J Chemother 1999; 11:407-409.
4. Price KS, Castells MC. Taxol reactions. Allergy Asthma Proc 2002;23: 205-208.
5. Gelderblom H, Verweij J, Nooter K, Sparreboom A. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer 2001;37:1590-1598.
6. Nuijen B, Bouma M, Schellens JH, Beijnen JH. Progress in the development of alternative pharmaceutical formulations of taxanes. Invest New Drugs 2001;19:143-153.
7. Decorti G, Klugmann FB, Candussio L, Baldini L. Effect of paclitaxel and Cremophor EL on mast cell histamine secretion and their interaction with adriamycin. Anticancer Res 1996;16:317-320.
8. Lorenz W, Reimann HJ, Schmal A, Dormann P, Schwarz B, Neugebauer E, Doenicke A. Histamine release in dogs by Cremophor E1 and its derivatives: oxethylated oleic acid is the most effective constituent. Agents Actions 1997;7:63-67.
9. Wiernik PH, Schwartz EL, Strauman JJ, Dutcher JP, Lipton RB, Paietta E. Phase I clinical and pharmacokinetic study of Taxol. Cancer Res 1987;47:2486-2493.
10. Bitton RJ, Figg WD, Reed E. A preliminary risk-benefit assessment of paclitaxel. Drug Saf 1995;12:196-208.
11. Boehm DK, Maksymiuk AW. Paclitaxel premedication regimens. J Natl Cancer Inst 1996;88:463-465.
12. Markman M, Kennedy A, Webster K, Peterson G, Kulp B, Belinson J. An effective and more convenient drug regimen for prophylaxis against paclitaxel-associated hypersensitivity reactions. J Cancer Res Clin Oncol 1999;125:427-429.
13. Kwon JS, Elit L, Finn M, Hirte H, Mazurka J, Moens F, Trim K. A comparison of two prophylactic regimens for hypersensitivity reactions to paclitaxel. Gynecol Oncol 2002;84:420-425.
14. Rowinsky EK, Donehower RC. Paclitaxel (Taxol). N Engl J Med 1995; 332:1004-1014.
15. Bookman MA, Kloth DD, Kover PE, Smolinski S, Ozols RF. Short-course intravenous prophylaxis for paclitaxel-related hypersensitivity reactions. Ann Oncol 1997;8:611-614.
16. Olson JK, Sood AK, Sorosky JI, Anderson B, Buller RE. Taxol hypersensitivity: rapid retreatment is safe and cost effective. Gynecol Oncol 1998;68:25-28.
17. Markman M, Kennedy A, Webster K, Kulp B, Peterson G, Belinson J. Paclitaxel-associated hypersensitivity reactions: experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center. J Clin Oncol 2000;18:102-105.
18. Baluk P. Neurogenic inflammation in skin and airways. J Investig Dermatol Symp Proc 1997;2:76-81.
19. Van Ransen ELJ, Hiemstra PS, Rabe KF, Sterk PJ. Assessment of microvascular leakage via sputum induction. Am J Respir Crit Care Med 2002;165:1275-1279.
20. Amadesi S, Moreau J, Tognetto M, Springer J, Trevisani M, Naline E, Advenier C, Fisher A, Vinci D, Mapp C, et al. NK1 receptor stimulation causes contraction and inositol phosphate increase in medium-size human isolated bronchi. Am J Respir Crit Care Med 2001;163:1206-1211.
21. Graham RM, Friedman M, Hoyle GW. Sensory nerves promote ozone-induced lung inflammation in mice. Am J Respir Crit Care Med 2001; 164:307-313.
22. Bret-Dibat JL, Creminon C, Couraud JY, Kelley KW, Dantzer R, Kent S. Systemic capsaicin pretreatment fails to block the decrease in food-motivated behavior induced by lipopolysaccharide and interleukin-1beta. Brain Res Bull 1997;42:443-449.
23. Sendo T, Kataoka Y, Takeda Y, Furuta W, Oishi R. Nitric oxide protects against contrast media-increased pulmonary vascular permeability in rats. Invest Radiol 2000;35:472-478.
24. Itoh Y, Oishi R, Adachi N, Saeki K. A highly sensitive assay for histamine using ion-pair HPLC coupled with postcolumn fluorescent derivatization: its application to biological specimens. J Neurochem 1992;58: 884-889.
25. Sendo T, Itoh Y, Goromaru T, Sumimura T, Saito M, Aki K, Yano T, Oishi R. A potent tryptase inhibitor nafamostat mesilate dramatically suppressed pulmonary dysfunction induced in rats by a radiographic contrast medium. Br J Pharmacol 2003;138:959-967.
26. 1 receptor antagonists in the anaesthetized rat. Eur J Pharmacol 1996;318:377-385.
27. 2) receptor. Life Sci 1992;50:PL101-PL106.
28. 8-37 on the in vivo regional haemodynamic actions of human alpha-CGRP. Biochem Biophys Res Commun 1990;171:938-943.
29. Kwon JS, Elit L, Finn M, Hirte H, Mazurka J, Moens F, Trim K. A comparison of two prophylactic regimens for hypersensitivity reactions to paclitaxel. Gynecol Oncol 2002;84:420-425.
30. Laroche D, Aimone-Gastin I, Dubois F, Huet H, Gerard P, Vergnaud MC, Mouton-Faivre C, Gueant JL, Laxenaire MC, Bricard H. Mechanisms of severe, immediate reactions to iodinated contrast material. Radiology 1998;209:35-36.
31. 2+ and cyclic AMP in mast cell histamine release induced by radiographic contrast media. Naunyn Schmiedeberg's Arch Pharmacol 2003;367:364-371.
32. 2 receptor antagonist. Eur J Pharmacol 1993;234:83-90.
33. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 1988;24:739-768.
34. Martling CR. Sensory nerves containing tachykinins and CGRP in the lower airways: functional implications for bronchoconstriction, vasodilation and protein extravasation. Acta Physiol Scand 1987;563:1-57.
35. Rogers DF, Belvisi MG, Aursudkij B, Evans TW, Barnes PJ. Effects and interactions of sensory neuropeptides on airway microvascular leakage in guinea-pigs. Br J Pharmacol 1988;95:1109-1116.
36. Marek W, Potthast JJ, Marcynski B, Baur X. Role of substance P and neurokinin A in toluene diisocyanate-induced increased airway responsiveness in rabbits. Lung 1996;174:83-97.
37. Strigas J, Burcher E. Autoradiographic localization of tachykinin NK2 and NK1 receptors in the guinea-pig lung, using selective radioligands. Eur J Pharmacol 1996;311:177-186.
38. Lundberg JM, Franco-Cereceda A, Hua XY, Hökfelt T, Fischer JA. Co-existence of substance P and calcitonin gene-related peptide immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin. Eur J Pharmacol 1985;108:315-319.
39. Martling CR. Sensory nerves containing tachykinins and CGRP in the lower airways: functional implications for bronchoconstriction, vasodilation and protein extravasation. Acta Physiol Scand 1987;563:1-57.
40. Rodger IW, Tousignant C, Young D, Savoie C, Chan CC. Neurokinin receptors subserving plasma extravasation in guinea pig airways. Can J Physiol Pharmacol 1995;73:927-931.